In this PharmTech video feature, we highlight the week’s industry news in an easy-to-consume, fun format. New roundups will drop every Friday, so be sure to come back each week.
Collectively, the week’s coverage discusses the pharmaceutical industry’s recent developments and current regulatory landscape. Read on for recaps of each story we’ve covered.
Mirum Pharmaceuticals acquired Bluejay Therapeutics to develop brelovitug, a late-stage monoclonal antibody treatment for chronic hepatitis delta virus patients.
The United States’ withdrawal from the WHO threatens global regulatory alignment, supply chain stability, and…
